Investors alleged that drugmaker Pfizer violated federal securities laws by making false, misleading or incomplete statements regarding the cardiovascular risks of Celebrex and Bextra. Seeger Weiss helped secure a $486 million settlement on behalf of the investors.
Prior results do not guarantee or predict a similar outcome in any future matter.
Best Lawyers® has issued the 15th edition of Best Law Firms® in the United States, recognizing Seeger Weiss with national and metropolitan rankings for the firm’s work in mass tort, product liability, environmental, and medical malpractice litigation. The Best Law Firms® rankings are a trusted standard in the legal profession, highlighting law firms that have […]
Seeger Weiss partners Parvin Aminolroaya, Shauna Itri, and Jennifer Scullion recently sat down with Litigation Daily to discuss their paths to securing leadership positions in multidistrict litigations (MDLs) and share insights on the evolving landscape of complex litigation leadership. The interview comes at a significant moment for all three partners, who have recently secured prominent […]
PHILADELPHIA, PA – Nationally recognized mass tort and class action law firm Seeger Weiss today announced the grand opening of its expanded Philadelphia presence in the historic Old City. The new 5,000-square-foot office near Independence Hall (325 Chestnut Street, Suite #917) positions the firm’s deep trial expertise steps from the federal courthouse and signals its […]
After being selected as a 2024 Law360 Product Liability MVP, Seeger Weiss co-founder Chris Seeger sat down with the publication to discuss his career journey and his advice to junior attorneys. Seeger found himself entering the product liability world after he “couldn’t connect” with corporate law. His first personal injury case changed everything for him. […]
Seeger Weiss attorneys played a key role in this case, helping negotiate an efficient and positive settlement for investor plaintiffs. Partner Dave Buchanan developed a slate of experts to overcome Pfizer’s early science challenges to the case. Founding partner Chris Seeger led the plaintiff’s presentation and examinations during the seven-day Daubert hearing.
Following pre-trial motion practice and ensuing appeals, Pfizer settled the case, resulting in a $486 million cash settlement fund for the class of aggrieved investors.
Pfizer allegedly misled shareholders about risks associated with two prescription medications: arthritis medication, Celebrex, and painkiller, Bextra. Evidence indicated that Pfizer recognized the potential cardiovascular risks of these medications but deliberately concealed these risks from shareholders. Plaintiffs alleged that these omissions violated federal securities laws, defrauding a class of investors.
Best Lawyers® has issued the 15th edition of Best Law Firms® in the United States, recognizing Seeger Weiss with national and metropolitan rankings for the firm’s work in mass tort, product liability, environmental, and medical malpractice litigation. The Best Law Firms® rankings are a trusted standard in the legal profession, highlighting law firms that have […]
Seeger Weiss partners Parvin Aminolroaya, Shauna Itri, and Jennifer Scullion recently sat down with Litigation Daily to discuss their paths to securing leadership positions in multidistrict litigations (MDLs) and share insights on the evolving landscape of complex litigation leadership. The interview comes at a significant moment for all three partners, who have recently secured prominent […]
PHILADELPHIA, PA – Nationally recognized mass tort and class action law firm Seeger Weiss today announced the grand opening of its expanded Philadelphia presence in the historic Old City. The new 5,000-square-foot office near Independence Hall (325 Chestnut Street, Suite #917) positions the firm’s deep trial expertise steps from the federal courthouse and signals its […]
After being selected as a 2024 Law360 Product Liability MVP, Seeger Weiss co-founder Chris Seeger sat down with the publication to discuss his career journey and his advice to junior attorneys. Seeger found himself entering the product liability world after he “couldn’t connect” with corporate law. His first personal injury case changed everything for him. […]